Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers I > Headlines for ISTA Pharmaceuticals Inc. > News item |
ISTA remains at sector perform by RBC
RBC Capital Markets analyst Douglas Miehm maintained ISTA Pharmaceuticals, Inc. at sector perform, speculative risk, after the company posted a third-quarter loss per share of $0.44 versus a loss per share of $0.35 in the third quarter the previous year and estimates of a loss per share of $0.31. Shares of the Irvine, Calif.-based pharmaceutical company were up 1 cent, or 0.16%, at $6.44, on volume of 28,559 shares versus the three-month running average of 49,234 shares. (Nasdaq: ISTA)
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.